VAERS Explorer
Back to explore

Report #2892977

Received Apr 16, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
LA
Recovered
Unknown
Vaccinated
Onset
Days to onset
Hospital days

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
FLU3INFLUENZA (SEASONAL) (FLUZONE)SANOFI PASTEURUNKUT879MA

Symptoms (2)

No adverse eventProduct storage issue

Symptom narrative

patient was given vaccine with this post-excursion with no AE; Initial information received on 01-Apr-2026 regarding an unsolicited valid non-serious case received from a healthcare professional (HCP). This case involves a patient of unknown age and unknown gender who received influenza USP trival A-B subvirion no preservative vaccine (Fluzone NP) with this post-excursion with no adverse event. The patient's past medical history, medical treatment(s), vaccination(s), family history were not provided. On an unknown date, the patient received a dose of unknown frequency of influenza USP trival A-B subvirion no preservative vaccine [Fluzone] suspension for injection (batch/lot number: UT879MA, expiry date: 30-Jun-2026) (strength: unknown) via unknown route in an unknown administration site for influenza (influenza immunization) post excursion with no adverse event (poor quality product administered, onset: unknown, latency: same day). Action taken: not applicable.

Medical history

Comments: NONE